Fairvalue-Calculator Fairvalue-Calculator
EN DE

Amrutanjan Health Care Limited (AMRUTANJAN) Fair Value & Analysis

Healthcare · IN · Market cap ₹15.5B

Price₹537.30
Fair Value₹374.06
Upside-30.4%
Quality97/100
Evidence: High Range ₹261.84 – ₹469.21

Fair value as of: Jun 29, 2026

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

Amrutanjan Health Care Limited (AMRUTANJAN) currently trades at ₹537.30, while our model-based Fair Value estimate is ₹374.06 — implying the stock looks roughly 30.4% overvalued today. We read business quality at 97/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Amrutanjan Health Care Limited manufactures, supplies, and sells ayurvedic pain balms and women hygiene products in India and internationally. It operates through OTC Products, Beverages, Women's Hygiene, and Others segments. The company provides pain management products comprising pain balms and roll-ons, back pain roll-ons, stick-on patch, and joint muscle sprays; dental pain gel; and decorn corn caps; hand sanitizer under the NOGerms brand name; and fruit and rehydration juice drinks under the Fruitnik brand name. The company also offers congestion management products that consists of cold rubs, cough syrups, nasal inhalers, and swas mints, as well as provides sanitary napkins for women. In addition, it operates a pain management center. The company was formerly known as Amrutanjan Limited and changed its name to Amrutanjan Health Care Limited in 2007. Amrutanjan Health Care Limited was founded in 1893 and is based in Chennai, India.

Open the full interactive analysis →

Similar stocks

Jiangsu Hengrui Pharmaceuticals Co (600276) -43% Sun Pharmaceutical Industries Limited (SUNPHARMA) -49% Zoetis Inc (Z1TS34) -24% Hansoh Pharmaceutical Group (3692) -18% Divi's Laboratories Limited (DIVISLAB) -81% Swedish Orphan Biovitrum AB (SOBI) -1%

Frequently asked questions

Is Amrutanjan Health Care Limited (AMRUTANJAN) undervalued?
As of Jun 29, 2026, our model estimates a fair value of ₹374.06 versus a price of ₹537.30 — about −30% (overvalued). Model-based estimate, not financial advice.
What is the fair value of AMRUTANJAN?
Our 21-model fair value for Amrutanjan Health Care Limited is ₹374.06 (as of Jun 29, 2026), built from audited fundamentals. The current price is ₹537.30.
What is the quality score of AMRUTANJAN?
Amrutanjan Health Care Limited has a Quality Score of 97/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.